Mar. Drugs 2013, 11(9), 3537-3553; doi:10.3390/md11093537
Article

Optimal Cleavage and Oxidative Folding of α-Conotoxin TxIB as a Therapeutic Candidate Peptide

email, email, email, email, email, * email and * email
Received: 5 August 2013; in revised form: 16 August 2013 / Accepted: 19 August 2013 / Published: 17 September 2013
(This article belongs to the Special Issue Conotoxins)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Alpha6beta2 nicotinic acetylcholine receptors (nAChRs) are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including addiction and Parkinson’s disease. Alpha-conotoxin (α-CTx) TxIB is a uniquely selective ligand, which blocks α6/α3β2β3 nAChRs only, but does not block the other subtypes. Therefore, α-CTx TxIB is a valuable therapeutic candidate peptide. Synthesizing enough α-CTx TxIB with high yield production is required for conducting wide-range testing of its potential medicinal applications. The current study optimized the cleavage of synthesized α-CTx TxIB resin-bounded peptide and folding of the cleaved linear peptide. Key parameters influencing cleavage and oxidative folding of α-CTx TxIB were examined, such as buffer, redox agents, pH, salt, co-solvent and temperature. Twelve conditions were used for cleavage optimization. Fifty-four kinds of one-step oxidative solution were used to assess their effects on each α-CTx TxIB isomers’ yield. The result indicated that co-solvent choices were particularly important. Completely oxidative folding of globular isomer was achieved when the NH4HCO3 or Tris-HCl folding buffer at 4 °C contained 40% of co-solvent DMSO, and GSH:GSSG (2:1) or GSH only with pH 8~8.7.
Keywords: α-conotoxin TxIB; oxidative folding; optimization; therapeutic peptides
PDF Full-text Download PDF Full-Text [1080 KB, uploaded 17 September 2013 11:06 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Wu, X.; Wu, Y.; Zhu, F.; Yang, Q.; Wu, Q.; Zhangsun, D.; Luo, S. Optimal Cleavage and Oxidative Folding of α-Conotoxin TxIB as a Therapeutic Candidate Peptide. Mar. Drugs 2013, 11, 3537-3553.

AMA Style

Wu X, Wu Y, Zhu F, Yang Q, Wu Q, Zhangsun D, Luo S. Optimal Cleavage and Oxidative Folding of α-Conotoxin TxIB as a Therapeutic Candidate Peptide. Marine Drugs. 2013; 11(9):3537-3553.

Chicago/Turabian Style

Wu, Xiaosa; Wu, Yong; Zhu, Furong; Yang, Qiuyuan; Wu, Qianqian; Zhangsun, Dongting; Luo, Sulan. 2013. "Optimal Cleavage and Oxidative Folding of α-Conotoxin TxIB as a Therapeutic Candidate Peptide." Mar. Drugs 11, no. 9: 3537-3553.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert